AVAH

TentativeAI MemoPost-earnings T+3

Aveanna Healthcare

As of 2026-08-18/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-18 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators; later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q2 beat and FY2026 guidance raise • 2026-08-13

Base target: $14 / p=50% prob

Biggest risk

Gross margin declined year over year despite revenue growth, and higher reimbursement is expected to be passed through partly as caregiver wages. Risks include fill-rate recovery, reimbursement timing, Family First integration, leverage, M&A discipline and recent large open-market sales by 10% owners. No post-print analyst revisions, target changes or estimate changes are available in the packet.

Invalidation

Break below $11 or thesis failure.

What would change my mind?

The Q2 operating result and higher FY2026 guidance support a constructive thesis, with preferred-payer expansion, reimbursement tailwinds and higher organic-growth targets providing potential upside. California reimbursement and caregiver-capacity improvements could add value in 2027.

Research note

Recommendation

—

Confidence

medium

As of

2026-08-18

Base target

$14

p=50%

Bull target

$16

p=25%

Bear target

$11

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Organic growth, integration and deleveraging
The Q2 operating result and higher FY2026 guidance support a constructive thesis, with preferred-payer expansion, reimbursement tailwinds and higher organic-growth targets providing potential upside.
California reimbursement and caregiver-capacity improvements could add value in 2027.

BearKey bullets

California reimbursement publication or implementation may be delayed.
Caregiver wage increases may offset reimbursement gains and limit margin expansion.
Family First integration and remaining back-office and EMR transitions are not complete.

WatchKey bullets

Q2 beat and FY2026 guidance raise

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $14 (p=50%)

Target spread vs base: +15% / -22%

Scenario probabilities

Bull Target: $16 (p=25%)Base Target: $14 (p=50%)Bear Target: $11 (p=25%)

Commentary

The August 13 SEC earnings exhibit was confirmed and supports the reported Q2 results and guidance increase. News tone is constructive, but no reliable event-window price reaction or post-print analyst revision set is available; the August 17 RankAlpha anchor alone cannot establish market reaction. Social coverage is unavailable and is not treated as positive evidence. Monitoring remains appropriate because margin pass-through, staffing recovery, reimbursement timing and integration execution are unresolved.

As of 2026-08-18 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Organic growth, integration and deleveraging

Scenarios

Bull Target (Scenario probability)

$16 / p=25% prob

Base Target (Scenario probability)

$14 / p=50% prob

Bear Target (Scenario probability)

$11 / p=25% prob

Analysis 2026-08-18 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.70

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-13
Q2 beat and FY2026 guidance raise
The company’s SEC Exhibit 99.1 confirms Q2 revenue of $670.5 million, up 13.7% year over year, adjusted EBITDA of $95.4 million, up 8.0%, and increased FY2026 guidance to above $2.68 billion of revenue and above $365 million of adjusted EBITDA. Stored earnings context reports adjusted EPS of $0.22 versus $0.17 consensus. [#SEC-8K-2026-08-13] [#PR-EARNINGS-2026-08-14]
Prob 80.00% • Move 6.00% • Priced-in 70.00%
EVENT2026-11-16
California reimbursement and caregiver-capacity execution
Stored earnings-call context reports a California 2027 pediatric private-duty nursing rate investment, expected Medi-Cal rate publication by the end of September 2026, and planned caregiver-wage pass-through before the reimbursement change. Execution could improve fill rates, but reimbursement-to-capacity conversion remains unproven. [#PR-EARNINGS-2026-08-14]
Prob 60.00% • Move 7.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

Organic growth, integration and deleveraging
2027-08-18
Stored earnings-call context reports higher long-term organic-growth targets for Private Duty Services and Home Health & Hospice, Family First integration tasks expected to finish by year-end 2026, and a management target for leverage below 3x in 2027. M&A remains active, but valuation discipline and execution are constraints. [#PR-EARNINGS-2026-08-14]
Prob 60% • Move 10% • Priced-in 50%

Risks

California reimbursement publication or implementation may be delayed.
Caregiver wage increases may offset reimbursement gains and limit margin expansion.
Family First integration and remaining back-office and EMR transitions are not complete.
Leverage may remain elevated if acquisition activity continues.
No verified post-earnings price reaction, analyst target revision or estimate revision is available.
Private-duty fill rates and staffing capacity remain execution-sensitive.
Recent open-market sales by 10% owners are a secondary sentiment overhang. [#SEC-FORM4-2026-07-02]

Peers

Symbol	Summary
ADUS	Direct home-based-care comparable spanning personal care, hospice and home health. Its older-adult mix and service composition differ from Aveanna, so peer read-through remains limited.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-18

Loading AI feed…

Symbol

Summary

ADUS

Direct home-based-care comparable spanning personal care, hospice and home health. Its older-adult mix and service composition differ from Aveanna, so peer read-through remains limited.